Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis - Final Results From the EMINENTS Study.

MTOR inhibitor everolimus maintenance therapy subependymal giant cell astrocytoma tuberous sclerosis

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2021
Historique:
received: 17 11 2020
accepted: 17 03 2021
entrez: 26 4 2021
pubmed: 27 4 2021
medline: 27 4 2021
Statut: epublish

Résumé

The aim of this EMINENTS prospective, single-center, open-label, single-arm study was to evaluate the cumulative efficacy and safety of reduced doses of everolimus (maintenance therapy) in patients with tuberous sclerosis and subependymal giant cell astrocytoma (SEGA).

Identifiants

pubmed: 33897576
doi: 10.3389/fneur.2021.581102
pmc: PMC8062974
doi:

Types de publication

Case Reports

Langues

eng

Pagination

581102

Informations de copyright

Copyright © 2021 Bobeff, Krajewska, Baranska, Kotulska, Jozwiak, Mlynarski and Trelinska.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Neurol. 2019 Aug 02;10:821
pubmed: 31428037
Orphanet J Rare Dis. 2019 Feb 13;14(1):39
pubmed: 30760308
J Child Neurol. 2014 Nov;29(11):1562-71
pubmed: 24105488
Ann Neurol. 2015 Dec;78(6):929-38
pubmed: 26381530
Lancet. 2013 Jan 12;381(9861):125-32
pubmed: 23158522
Anticancer Drugs. 2015 Apr;26(4):437-42
pubmed: 25719621
Pediatr Nephrol. 2015 Jan;30(1):173-7
pubmed: 25194630
Orphanet J Rare Dis. 2017 Feb 15;12(1):35
pubmed: 28202028
Pediatr Blood Cancer. 2015 Apr;62(4):616-21
pubmed: 25557360
MAGMA. 2017 Aug;30(4):397-405
pubmed: 28321524
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jun 1;928:9-15
pubmed: 23584041
Pharmacol Rep. 2016 Jun;68(3):536-42
pubmed: 26891243
Pediatr Blood Cancer. 2017 Jun;64(6):
pubmed: 27860334
PLoS One. 2016 Jun 28;11(6):e0158476
pubmed: 27351628
BMC Neurol. 2016 Aug 08;16:126
pubmed: 27502586
Pediatr Blood Cancer. 2015 Oct;62(10):1754-60
pubmed: 25929843
N Engl J Med. 2010 Nov 4;363(19):1801-11
pubmed: 21047224
Curr Neurol Neurosci Rep. 2016 Dec;16(12):102
pubmed: 27815691

Auteurs

Katarzyna Bobeff (K)

Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

Karolina Krajewska (K)

Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

Dobromila Baranska (D)

Department of Pediatric Radiology, Medical University Hospital, Lodz, Poland.

Katarzyna Kotulska (K)

Department of Neurology & Epileptology and Pediatric Rehabilitation, The Children's Memorial Health Institute, Warsaw, Poland.

Sergiusz Jozwiak (S)

Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland.

Wojciech Mlynarski (W)

Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

Joanna Trelinska (J)

Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

Classifications MeSH